Showing results (511-520 of 1,188) with videos related to

Sort By:
Pageof 119
Blood|November 8, 2003
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignanciesJean-Pierre J Issa, Guillermo Garcia-Manero, Francis J Giles, et al.
Haematologica|June 30, 2017
Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutationRashmi Kanagal-Shamanna, Sanam Loghavi, Courtney D DiNardo, et al.
Cancer|January 28, 2012
Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patientsStefan Faderl, Farhad Ravandi, Xuelin Huang, et al.
Cancer|July 12, 2008
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring SystemHagop Kantarjian, Susan O'Brien, Farhad Ravandi, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2010
Feasibility of therapy with hypomethylating agents in patients with renal insufficiencyG Nicolas Batty, Hagop Kantarjian, Jean-Pierre Issa, et al.
Annals of Hematology|May 11, 2013
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromesBin Fu, Chi Young Ok, Maitrayee Goswami, et al.
Cancer|July 31, 2010
Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding studyMarcos de Lima, Sergio Giralt, Peter F Thall, et al.
Blood|July 30, 2010
Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemiaHagop Kantarjian, Farhad Ravandi, Susan O'Brien, et al.
Plos One|December 19, 2013
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or bIlaria Lepore, Carmela Dell'Aversana, Maxim Pilyugin, et al.
Blood|April 9, 2004
High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemiaHagop Kantarjian, Moshe Talpaz, Susan O'Brien, et al.
Pageof 119